Drug Shortage Report for ERYTHROCIN I.V.
Report ID | 169767 |
Drug Identification Number | 00682268 |
Brand name | ERYTHROCIN I.V. |
Common or Proper name | Erythromycin Lactobionate for Injection |
Company Name | AMDIPHARM LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | ERYTHROMYCIN |
Strength(s) | 500MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 10 vials |
ATC code | J01FA |
ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2022-09-23 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | 2022-09-26 |
Shortage status | Resolved |
Updated date | 2022-09-27 |
Company comments | Delay in release. As of Sept 26 2022, release resolved. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3 BURLINGTON ROAD DUBLIN, LEINSTER IRELAND DUBLIN 4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2022-09-27 | English | Compare |
v10 | 2022-09-26 | French | Compare |
v9 | 2022-09-26 | French | Compare |
v8 | 2022-09-26 | French | Compare |
v7 | 2022-09-26 | English | Compare |
v6 | 2022-09-24 | English | Compare |
v5 | 2022-09-22 | French | Compare |
v4 | 2022-09-22 | English | Compare |
v3 | 2022-09-22 | French | Compare |
v2 | 2022-09-22 | English | Compare |
v1 | 2022-09-22 | English | Compare |
Showing 1 to 11 of 11